Literature DB >> 15941804

Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing.

Madhukar Pai1, Kaustubh Gokhale, Rajnish Joshi, Sandeep Dogra, Shriprakash Kalantri, Deepak K Mendiratta, Pratibha Narang, Charles L Daley, Reuben M Granich, Gerald H Mazurek, Arthur L Reingold, Lee W Riley, John M Colford.   

Abstract

CONTEXT: Mycobacterium tuberculosis infection in health care workers has not been adequately studied in developing countries using newer diagnostic tests.
OBJECTIVES: To estimate latent tuberculosis infection prevalence in health care workers using the tuberculin skin test (TST) and a whole-blood interferon gamma (IFN-gamma) assay; to determine agreement between the tests; and to compare their correlation with risk factors. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional comparison study of 726 health care workers aged 18 to 61 years (median age, 22 years) with no history of active tuberculosis conducted from January to May 2004, at a rural medical school in India. A total of 493 (68%) of the health care workers had direct contact with patients with tuberculosis and 514 (71%) had BCG vaccine scars.
INTERVENTIONS: Tuberculin skin testing was performed using 1-TU dose of purified protein derivative RT23, and the IFN-gamma assay was performed by measuring IFN-gamma response to early secreted antigenic target 6, culture filtrate protein 10, and a portion of tuberculosis antigen TB7.7. MAIN OUTCOME MEASURES: Agreement between TST and the IFN-gamma assay, and comparison of the tests with respect to their association with risk factors.
RESULTS: A large proportion of the health care workers were latently infected; 360 (50%) were positive by either TST or IFN-gamma assay, and 226 (31%) were positive by both tests. The prevalence estimates of TST and IFN-gamma assay positivity were comparable (41%; 95% confidence interval [CI], 38%-45% and 40%; 95% CI, 37%-43%, respectively). Agreement between the tests was high (81.4%; kappa = 0.61; 95% CI, 0.56-0.67). Increasing age and years in the health profession were significant risk factors for both IFN-gamma assay and TST positivity. BCG vaccination had little impact on TST and IFN-gamma assay results.
CONCLUSIONS: Our study showed high latent tuberculosis infection prevalence in Indian health care workers, high agreement between TST and IFN-gamma assay, and similar association between positive test results and risk factors. Although TST and IFN-gamma assay appear comparable in this population, they have different performance and operational characteristics; therefore, the decision to select one test over the other will depend on the population, purpose of testing, and resource availability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15941804     DOI: 10.1001/jama.293.22.2746

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  107 in total

1.  Latent tuberculosis infection screening for laboratory personnel using interferon-γ release assay and tuberculin skin test in Korea: an intermediate incidence setting.

Authors:  Hee-Won Moon; Hanah Kim; Mina Hur; Yeo-Min Yun; Anna Lee
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

2.  An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.

Authors:  Luigi Codecasa; Paola Mantegani; Laura Galli; Adriano Lazzarin; Paolo Scarpellini; Claudio Fortis
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Whole blood IFN-gamma assay for detecting TB in children.

Authors:  A J Radford; J S Rothel; G Sberna
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

4.  Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models.

Authors:  M Pai; N Dendukuri; L Wang; R Joshi; S Kalantri; H L Rieder
Journal:  Int J Tuberc Lung Dis       Date:  2008-08       Impact factor: 2.373

5.  The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis.

Authors:  Benjamin D Fox; Mordechai R Kramer; Zohar Mor; Rachel Preiss; Victoria Rusanov; Leonardo Fuks; Nir Peled; Ilanit Haim; Meir Raz; David Shitrit
Journal:  Lung       Date:  2009-10-15       Impact factor: 2.584

6.  Diagnostic value of interferon- gamma release assays (QuantiFERON-TB Gold® In Tube) in childhood tuberculosis.

Authors:  Rajeshwar Dayal; Vikas Verma; B Sharma; G Kumar; N Kumar; R Gupta; V M Katoch; Beenu Joshi; D S Chauhan
Journal:  Indian J Pediatr       Date:  2011-06-25       Impact factor: 1.967

7.  Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children.

Authors:  K Okada; T E Mao; T Mori; T Miura; T Sugiyama; T Yoshiyama; S Mitarai; I Onozaki; N Harada; S Saint; K S Kong; Y M Chhour
Journal:  Epidemiol Infect       Date:  2007-11-08       Impact factor: 2.451

8.  Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals.

Authors:  Naasha J Talati; Ulrich Seybold; Bianca Humphrey; Abiola Aina; Jane Tapia; Paul Weinfurter; Rachel Albalak; Henry M Blumberg
Journal:  BMC Infect Dis       Date:  2009-02-10       Impact factor: 3.090

9.  Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers.

Authors:  Irma Casas; Irene Latorre; Maria Esteve; Juan Ruiz-Manzano; Dora Rodriguez; Cristina Prat; Ignasi García-Olivé; Alicia Lacoma; Vicente Ausina; Jose Domínguez
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

10.  Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam.

Authors:  Luu Thi Lien; Nguyen Thi Le Hang; Nobuyuki Kobayashi; Hideki Yanai; Emiko Toyota; Shinsaku Sakurada; Pham Huu Thuong; Vu Cao Cuong; Akiko Nanri; Tetsuya Mizoue; Ikumi Matsushita; Nobuyuki Harada; Kazue Higuchi; Le Anh Tuan; Naoto Keicho
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.